1. Home
  2. BW vs BMEA Comparison

BW vs BMEA Comparison

Compare BW & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BW
  • BMEA
  • Stock Information
  • Founded
  • BW 1867
  • BMEA 2017
  • Country
  • BW United States
  • BMEA United States
  • Employees
  • BW N/A
  • BMEA N/A
  • Industry
  • BW Building Products
  • BMEA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BW Industrials
  • BMEA Health Care
  • Exchange
  • BW Nasdaq
  • BMEA Nasdaq
  • Market Cap
  • BW 119.1M
  • BMEA 96.9M
  • IPO Year
  • BW N/A
  • BMEA 2021
  • Fundamental
  • Price
  • BW $6.73
  • BMEA $1.28
  • Analyst Decision
  • BW Buy
  • BMEA Strong Buy
  • Analyst Count
  • BW 2
  • BMEA 7
  • Target Price
  • BW $5.50
  • BMEA $8.71
  • AVG Volume (30 Days)
  • BW 5.8M
  • BMEA 1.4M
  • Earning Date
  • BW 11-04-2025
  • BMEA 11-04-2025
  • Dividend Yield
  • BW N/A
  • BMEA N/A
  • EPS Growth
  • BW N/A
  • BMEA N/A
  • EPS
  • BW N/A
  • BMEA N/A
  • Revenue
  • BW $721,285,000.00
  • BMEA N/A
  • Revenue This Year
  • BW N/A
  • BMEA N/A
  • Revenue Next Year
  • BW $8.02
  • BMEA N/A
  • P/E Ratio
  • BW N/A
  • BMEA N/A
  • Revenue Growth
  • BW 57.75
  • BMEA N/A
  • 52 Week Low
  • BW $0.22
  • BMEA $1.22
  • 52 Week High
  • BW $7.77
  • BMEA $7.50
  • Technical
  • Relative Strength Index (RSI)
  • BW 74.73
  • BMEA 38.07
  • Support Level
  • BW $4.65
  • BMEA $1.24
  • Resistance Level
  • BW $7.77
  • BMEA $1.42
  • Average True Range (ATR)
  • BW 0.65
  • BMEA 0.08
  • MACD
  • BW 0.27
  • BMEA 0.01
  • Stochastic Oscillator
  • BW 76.34
  • BMEA 28.10

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.

Share on Social Networks: